16 September 2026 editorial review · Item
Oral glucose tolerance test (OGTT) for T1D staging: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: reviewed; no confirmed content change. Current item
lastReviewed: 2026-08-27. - Claim check: 2024 monitoring consensus supports OGTT as metabolic staging test, not a convenient first-line general-population antibody screen. No result/treatment conflation.
- Registry NCT00097292: RECRUITING; updated 2025-07-01; enrollment 75000 (ESTIMATED); primary completion 2030-07-31 (ESTIMATED); results not posted in retrieved record.
- Primary publication/regulatory sources checked or consulted: dci24-0042.